AFG Fiduciary Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
1,856
-629
-25% -$85K 0.23% 51
2026
Q1
$320K Sell
2,485
-144
-5% -$18K 0.19% 68
2025
Q4
$319K Sell
2,629
-382
-13% -$43.8K 0.19% 69
2025
Q3
$305K Sell
3,011
-24
-0.8% -$2.16K 0.18% 70
2025
Q2
$252K Sell
3,035
-60
-2% -$4.79K 0.16% 74
2025
Q1
$232K Buy
3,095
+21
+0.7% +$1.88K 0.17% 66
2024
Q4
$272K Sell
3,074
-5,585
-64% -$541K 0.19% 63
2024
Q3
$854K Sell
8,659
-78
-0.9% -$7.66K 0.58% 34
2024
Q2
$864K Buy
8,737
+439
+5% +$39.4K 0.6% 33
2024
Q1
$760K Sell
8,298
-388
-4% -$36K 0.56% 35
2023
Q4
$811K Sell
8,686
-485
-5% -$36K 0.66% 32
2023
Q3
$638K Buy
9,171
+1,019
+13% +$81.4K 0.57% 34
2023
Q2
$688K Buy
+8,152
New +$682K 0.52% 38
2023
Q1
Sell
-7,451
Closed -$618K 88
2022
Q4
$618K Sell
7,451
-180
-2% -$14.6K 0.58% 33
2022
Q3
$605K Sell
7,631
-700
-8% -$59K 0.57% 35
2022
Q2
$619K Buy
8,331
+334
+4% +$25.1K 0.54% 45
2022
Q1
$719K Sell
7,997
-1,439
-15% -$133K 0.51% 42
2021
Q4
$1.06M Buy
+9,436
New +$1.14M 0.74% 27

Other funds holding XBI

AFG Fiduciary Services's XBI Position: Q2 2026 in Review

AFG Fiduciary Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 25% in Q2 2026, selling an estimated $85K and leaving 1,856 shares worth $298K. The position accounts for 0.23% of the portfolio, ranked #51.

AFG Fiduciary Services first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.06M in Q4 2021. 179 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • AFG Fiduciary Services held 1,856 shares of State Street SPDR S&P Biotech ETF worth $298K as of Q2 2026.
  • AFG Fiduciary Services sold 629 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $85K.
  • State Street SPDR S&P Biotech ETF made up 0.23% of AFG Fiduciary Services's portfolio in Q2 2026, its #51 holding.
  • AFG Fiduciary Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
  • AFG Fiduciary Services's State Street SPDR S&P Biotech ETF position peaked at $1.06M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on AFG Fiduciary Services's 13F filing for Q2 2026, filed 9 Jul 2026.